Alimera Sciences Prices Low IPO

Published: Apr 22, 2010

Pehub.com -- Alimera Sciences Inc., an Atlanta-based ophthalmic pharmaceutical company, raised around $72 million in its IPO. The company sold 6.5 million common shares at $11 per share, compared to original plans to sell 6 million shares bat between $15 and $17 per share.

Back to news